Concepedia

Margaret McFarland

MM

15

Publications

2.3K

Citations

13

H-Index

2003

Active since

Affiliations

University of Ulster(Current)

Royal Victoria Hospital

King's College London

Belfast Health and Social Care Trust

Queen's University Belfast

Margaret McFarland is an author at University of Ulster specializing in medicine, pharmacology, and cell death.

Top concepts

Publications per year

2003–2023

15

Publications

15

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon et al. · The Lancet · 2020 · 601 citations · Full text

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Resveratrol is a potent inducer of apoptosis in human melanoma cells

Richard M. Niles, Margaret McFarland, Mathew B. Weimer et al. · Cancer Letters · 2003 · 154 citations

, , +10

Rows per page

1–5 of 15